Market Value5,412,850,000
Total Holdings39
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CBAY / CymaBay Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
FENC / Fennec Pharmaceuticals Inc.
NUVL / Nuvalent, Inc.
TNGX / Tango Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
IOBT / IO Biotech, Inc.
RNA / Avidity Biosciences, Inc.
BCAB / BioAtla, Inc.
APLS / Apellis Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
KYMR / Kymera Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
GNCA / Genocea Biosciences Inc
AMTI / Applied Molecular Transport Inc.
UTHR / United Therapeutics Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
DICE / DICE Therapeutics Inc
IOVA / Iovance Biotherapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
MNKD / MannKind Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
DSGN / Design Therapeutics, Inc.
ISEE / IVERIC bio Inc
SGEN / Seagen Inc
BCRX / BioCryst Pharmaceuticals, Inc.
WHWK / Whitehawk Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
FOLD / Amicus Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
KURA / Kura Oncology, Inc.
MRNS / Marinus Pharmaceuticals, Inc.